Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
06/2007
06/07/2007US20070126345 Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof
06/06/2007CN1319957C Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
05/2007
05/30/2007EP1003730B1 2-benzoyl-cyclohexane-1,3-diones
05/29/2007US7223868 Heteroaromatic glucokinase activators
05/29/2007US7223768 Fused ring heterocycles as potassium channel modulators
05/29/2007US7223762 Bind to Very Late Antigen-4 (VLA-4); treating asthma; 3-(5-(2-Methylphenyl)-2-(N-cyclohexyl-N-methylamino)pyrimidin-4-ylamino)-3-(4-(dimethylaminocarbonyl)oxyphenyl)propanoic Acid for example
05/29/2007US7223484 2,1,3-benzothiadiazoles for use as electronic active components
05/24/2007WO2007057093A1 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazine derivatives
05/24/2007WO2007057092A1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazines
05/24/2007US20070113727 Wireless microphone communication system
05/24/2007CA2630203A1 3,6-dihydro-2-oxo-6h-1,3,4-thiadiazine derivatives
05/24/2007CA2630202A1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h[1,3,4]-thiadiazines
05/22/2007US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease
05/22/2007US7220745 Viricides; therapy for hepatitis virus infections
05/22/2007CA2368347C Glucokinase activators
05/18/2007WO2007056469A2 Certain chemical entities, compositions, and methods
05/18/2007WO2007054601A1 1,1-dioxo-1,2,6-thadiazine 2-substituted 5-carboxylate and 5-carboxamide derivatives with cannabinoid properties
05/18/2007WO2007054257A2 Indene derivatives, their preparation and use as medicaments
05/18/2007CA2628856A1 Indene derivatives, their preparation and use as medicaments
05/17/2007US20070112045 Triazole ppar modulators
05/17/2007US20070112044 Antitumor, anticancer agents; using a 2-amino-5-phenyl-(1,3,4)thiadiazole compound
05/16/2007EP1684752B1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists
05/15/2007US7217728 For therapy of reperfusion injury
05/15/2007CA2301194C Method for the production of 3-isopropyl-1h-2,1,3-benzothiadiazine-4(3h)-one-2,2-dioxide
05/09/2007EP1781630A1 Novel piperidine derivative for the treatment of depression
05/09/2007CN1960978A Amine compound and organic electroluminescent element employing the same
05/08/2007US7214712 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
05/03/2007WO2007049828A1 Therapeutic agent for unstable cerebrospinal pressure syndrome
05/03/2007US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
05/03/2007US20070099898 2,4-benzodiazepine derivatives, used for treating cardiovascular diseases, cognitive and neurodegenerative diseases
05/02/2007EP1778617A1 Process for preparing nitrooxy esters, nitrooxy thioesters, nitrooxy carbonates and nitrooxy thiocarbonates, intermediates useful in said process and preparation thereof
05/02/2007EP1658285B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
05/01/2007US7211592 Substituted an unsubstituted benzooxathiazoles and compounds derived therefrom
05/01/2007CA2351612C Thiadiazole additives and lubricating compositions containing the same
05/01/2007CA2305458C Nonsteroidal (hetero) cyclically-substituted acylanilides with mixed gestagenic and androgenic activity
04/2007
04/26/2007WO2007017511A3 Compounds for treating alzheimer's disease
04/26/2007WO2006120133A3 Process for coloring keratin fibers comprising metal complexes
04/25/2007CN1312139C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
04/24/2007US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
04/24/2007US7208509 Non-nucleoside reverse transcriptase inhibitors
04/24/2007US7208503 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
04/24/2007CA2171934C Endothelin receptor antagonists
04/24/2007CA2075173C Compounds and methods for inhibition of hiv and related viruses
04/18/2007EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007CN1948307A Preparation method of 5-(2-pyridyl)-2-sulfhydryl-1,3,4-thiadiazole
04/18/2007CN1948295A Preparation method of 5-(2-phenyl)-2-mercapto-1,3,4-thiadiazole
04/18/2007CN1948286A Salt of carboxylic acid containing N-substituted succinimide thio group and unvulcanized rubber composition containing the same
04/12/2007WO2007041366A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
04/12/2007WO2007041258A1 Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake
04/12/2007WO2007039175A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
04/12/2007WO2007039173A1 Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
04/12/2007WO2007039171A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/12/2007CA2624726A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
04/12/2007CA2624681A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
04/12/2007CA2624326A1 Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
04/12/2007CA2624096A1 Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake
04/12/2007CA2623045A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
04/11/2007EP1771421A1 N-hydroxyamide derivatives and use thereof
04/11/2007EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives
04/11/2007EP1015439B1 Prenyl transferase inhibitors
04/11/2007CN1946398A Thiadiazolidinones as gsk-3 inhibitors
04/05/2007WO2007037187A1 Sulfonamide derivative having pgd2 receptor antagonistic activity
04/05/2007CA2621310A1 Sulfonamide derivative having pgd2 receptor antagonistic activity
04/04/2007CN1942457A 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
04/04/2007CN1308317C New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
04/04/2007CN1308316C Alpha-phenyl-beta-ketosulfone
04/03/2007US7199167 Formed from mesogen such as 2,7-bis{5-[4-(8-diallylaminooctyloxy)phenyl]-thien-2-yl}-9,9-dipropylfluorene; photopolymerization without photoinitiator; lowcost, bright, portable displays; simple manufacturing, enhanced power and transmission efficiency; does not require polarizer
04/03/2007CA2294581C Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
03/2007
03/28/2007EP1765798A2 1,2,4- thiadiazole compounds and pests controlling composition containing the same
03/28/2007EP1765793A1 Cetp inhibitors
03/28/2007CN1938279A Modulators of atp-binding cassette transporters
03/28/2007CN1938266A Sulfonamide compounds for the treatment of neurodegenerative disorders
03/28/2007CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
03/27/2007US7196194 for color photography
03/27/2007US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/27/2007US7196087 useful for modulating the 5-HT6 receptor, the 5-HT2A receptor, or both; useful in the treatment of certain CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's
03/27/2007CA2193460C 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation
03/22/2007WO2007031513A1 Pesticide thiazolyloxy substituted phenylamidine derivatives
03/22/2007WO2006105127A3 Hydroxysteroid dehydrogenase inhibitors
03/22/2007US20070066658 N-{4-[4-(2-Benzylamino-ethyl)-phenoxy]-phenyl}-acetamide; eating disorders; antidiabetic, -arthritic, -epileptic, anxiolytic -lipedemic agents; anxiolytic, hypoglycemic and hypotensive agents; sexual disorders, antidepressants, hypertriglycemia, hyperlipoproteinemia, drug abuse; behavior disorders
03/22/2007US20070066614 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1
03/22/2007CA2619059A1 Pesticide thiazolyloxy substituted phenylamidine derivatives
03/20/2007US7192953 Antibacterial agents
03/20/2007US7192950 Psychological disorders; eating disorders; dietetics
03/20/2007CA2220094C Process for producing guanidine derivatives, intermediates therefor and their production
03/15/2007US20070060586 Nitrooxyderivatives of antihypertensive drugs
03/14/2007EP1562936B1 Therapeutic piperazine compounds
03/14/2007CN1930121A Substituted heteroaryl- and phenylsulfamoyl compounds
03/14/2007CN1929737A Hiv整合酶抑制剂 Hiv integrase inhibitors
03/13/2007CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
03/13/2007CA2274756C Methods and pharmaceutical compositions for inhibiting tumour cell growth
03/08/2007WO2007026376A2 A novel process for preparation of highly pure crystalline hydrochlorothiazide
03/08/2007US20070054897 1,1-Dicyclohexyl-3-thiazol-2-yl-urea, 3-(5-Chloro-thiazol-2-yl)-1,1-dicyclohexyl-urea, for example; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes
03/08/2007US20070054883 Use controlling growth of quorum-sensing bacteria, controlling biofilm formation, including biofilm growth; cyclic borate, phosphate or sulfate compounds
03/07/2007EP1758873A1 Ubiquitin ligase inhibitors
03/07/2007CN1923794A Process for production of high-purity enamines
03/07/2007CN1303071C Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof
03/06/2007US7186725 Anti-inflammatory compositions and methods
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 100